New migraine drugs
Cephalalgia
.
2023 Mar;43(3):3331024221144784.
doi: 10.1177/03331024221144784.
Authors
Francesca Puledda
1
,
Cristina Tassorelli
2
3
,
Hans Christoph Diener
4
Affiliations
1
Basic and Clinical Neuroscience, King's College London, London, UK.
2
Headache Science Center, IRCCS Mondino Foundation, Pavia, Italy.
3
Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
4
Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), Medical Faculty of the University Duisburg-Essen, Essen, Germany.
PMID:
36786364
DOI:
10.1177/03331024221144784
No abstract available
Publication types
Editorial
MeSH terms
Humans
Migraine Disorders* / drug therapy